HRMY
Harmony Biosciences Holdings, IHealthcare$27.74
▼ Bearish
Mkt Cap: $1.60B|Float: 50.9M|SI: 15.0%|DTC: 5.6
Data as of market close Apr 2, 2026
IV Rank
45
IV Pctl
67%
HV 20d
26.5%
52W Range
$26-$41
ATR(14)
$0.83
Exp. Move
±15.3%
P/C Ratio
1.56
Earnings
May 5
GEX Negative
DEX Long
Net Put Premium
IV Moderate
Max Pain Above
Exp. Move Wide
High Put/Call
HRMY Key Options Data
- IV Rank
- 45%
- Total GEX
- $-0.00B
- Total DEX
- $0.6M
- Max Pain
- $30.00
- Expected Move
- ±15.3%
- Put/Call OI
- 1.56
- Net Premium
- $-0.0M
- Spot Price
- $27.74
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$4.25 | ±15.3% | $23.49 | $31.99 |
| 2026-07-17 | 106 | ±$8.93 | ±32.2% | $18.81 | $36.66 |
| 2026-10-16 | 197 | ±$6.00 | ±21.6% | $21.74 | $33.74 |
| 2026-12-18 | 260 | ±$13.05 | ±47.0% | $14.69 | $40.79 |
Explore HRMY options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.